{"transactions":[{"id":4021795,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-02T21:06:15.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":27984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 27, 2017, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 2 and 3."},{"field":"date","element":"transactionDate","label":"F2","text":"On March 2, 2018, the Compensation Committee determined and certified that 55% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in three equal installments on the following dates: March 2, 2018, January 1, 2019, and January 1, 2020."}],"balance_after":27984,"derivative":{"exercise_price":50.13,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":27984},"source":{"system":"sec-edgar","filing":"0001171843-18-001655","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318001655/formfour.xml","form_type":"4"}},{"id":4088837,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2018-01-26T21:09:52.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":57100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted stock awards vest in four equal annual installments beginning January 24, 2019."}],"balance_after":189891,"source":{"system":"sec-edgar","filing":"0001171843-18-000695","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000695/formfour.xml","form_type":"4"}},{"id":4180305,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2017-10-26T20:06:50.000Z","date":"2017-10-24","kind":"sale","acquired":false,"shares":3278,"price":60.04,"value":196811.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 24, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 3,278 shares in multiple trades ranging from $60.00 to $60.10. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":132791,"source":{"system":"sec-edgar","filing":"0001171843-17-006332","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317006332/formfour.xml","form_type":"4"}},{"id":4181502,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2017-10-24T20:05:24.000Z","date":"2017-10-23","kind":"sale","acquired":false,"shares":22228,"price":60.06,"value":1335013.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 23, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 22,228 shares in multiple trades ranging from $60.00 to $60.22. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":136069,"source":{"system":"sec-edgar","filing":"0001171843-17-006236","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317006236/formfour.xml","form_type":"4"}},{"id":4181501,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2017-10-24T20:05:24.000Z","date":"2017-10-20","kind":"sale","acquired":false,"shares":5991,"price":60.04,"value":359699.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 20, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 5,991 shares in multiple trades ranging from $60.00 to $60.13. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":158297,"source":{"system":"sec-edgar","filing":"0001171843-17-006236","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317006236/formfour.xml","form_type":"4"}},{"id":4184250,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2017-10-18T20:05:27.000Z","date":"2017-10-16","kind":"sale","acquired":false,"shares":3293,"price":60.04,"value":197711.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 16, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 3,293 shares in multiple trades ranging from $60.00 to $60.14. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"source":{"system":"sec-edgar","filing":"0001171843-17-006128","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317006128/formfour.xml","form_type":"4"}},{"id":4185984,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2017-10-16T20:05:25.000Z","date":"2017-10-13","kind":"sale","acquired":false,"shares":5216,"price":60.11,"value":313533.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 13, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 5,216 shares in multiple trades ranging from $60.00 to $60.17. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":167581,"source":{"system":"sec-edgar","filing":"0001171843-17-006079","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317006079/formfour.xml","form_type":"4"}},{"id":4185983,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2017-10-16T20:05:25.000Z","date":"2017-10-12","kind":"sale","acquired":false,"shares":1908,"price":60,"value":114480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 12, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 1,908 shares in a single trade at $60.00."}],"balance_after":172797,"source":{"system":"sec-edgar","filing":"0001171843-17-006079","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317006079/formfour.xml","form_type":"4"}},{"id":4248830,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Director"}}],"security":"Common Stock","published_at":"2017-07-31T20:15:44.000Z","date":"2017-07-27","kind":"sale","acquired":false,"shares":63799,"price":50.79,"value":3240351.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 27, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 63,799 shares in multiple trades ranging from $50.00 to $52.05. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":174705,"source":{"system":"sec-edgar","filing":"0001171843-17-004472","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317004472/formfour.xml","form_type":"4"}},{"id":4262554,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2017-07-06T22:30:25.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":8236,"price":50.06,"value":412294.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 5, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 8,236 shares in multiple trades ranging from $50.00 to $50.25. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":238504,"source":{"system":"sec-edgar","filing":"0001171843-17-003991","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317003991/formfour.xml","form_type":"4"}},{"id":4262553,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Common Stock","published_at":"2017-07-06T22:30:25.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":5965,"price":50,"value":298250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 3, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 5,965 shares in multiple trades ranging from $50.00 to $50.02. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":246740,"source":{"system":"sec-edgar","filing":"0001171843-17-003991","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317003991/formfour.xml","form_type":"4"}},{"id":4419070,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-28T21:07:21.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, February 4, 2016, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 2 and 3."},{"field":"date","element":"transactionDate","label":"F2","text":"On February 24, 2017, the Compensation Committee determined and certified that 125% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in four equal installments on the following dates: February 24, 2017, January 1, 2018, January 1, 2019 and January 1, 2020."}],"balance_after":39375,"derivative":{"exercise_price":38.11,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001171843-17-001208","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001208/formfour.xml","form_type":"4"}},{"id":4475947,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":168767,"kind":"person","name":"SHERWOOD CHARLES H","position":1,"cik":"0001244298","reported_name":"SHERWOOD CHARLES H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T21:10:07.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three equal annual installments beginning January 27, 2018."}],"balance_after":125000,"derivative":{"exercise_price":50.13,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001171843-17-000590","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317000590/formfour.xml","form_type":"4"}}]}